equityflowunderstand the flow and follow it
EquityFlowCompanies › Asimov

Asimov Y Combinator · Winter 2026

Biotech · Boston, US · asimov.com

Synthetic biology design tools

Real-world human movement data for humanoid robots

Founders

Team & hubs

In the network

Shares the most investors with (number = shared investors):

Funding history

DateRoundAmount
Jan 2023Series B
Asimov, a US synthetic-biology startup, raised a USD175M Series B (USD200M total) led by CPP Investments.
$200M

Investors

Tap an investor to see what else they have backed.

Other companies in Biotech

Other companies in US

Other companies at Series B stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.